Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Bionime Corporation

Market Cap 4.4B 139M 121M 112M 105M 197M 13.12B 198M 1.33B 516M 6.46B 522M 511M 22.4B P/E 2024
-31x
P/E 2025 -22.2x
Enterprise Value 6.97B 221M 192M 177M 167M 312M 20.79B 314M 2.11B 819M 10.25B 828M 810M 35.51B EV / Sales 2024
3.48x
EV / Sales 2025 3.58x
Free-Float
53.01%
Yield 2024 *
-
Yield 2025 -
1 day+1.25%
1 week+3.83%
Current month-0.35%
1 month-6.11%
3 months-8.23%
6 months-1.90%
Current year-4.37%
1 week 53.9
Extreme 53.9
57.8
1 month 49.75
Extreme 49.75
60
Current year 49.75
Extreme 49.75
72.9
1 year 49.75
Extreme 49.75
73.9
3 years 43.14
Extreme 43.1415
81.92
5 years 43.14
Extreme 43.1415
88.92
10 years 40
Extreme 40.0048
88.92
Manager TitleAgeSince
Chief Executive Officer - 08/07/2010
Director of Finance/CFO - 05/11/2017
Chief Tech/Sci/R&D Officer - 06/11/2018
Director TitleAgeSince
Chairman - 13/04/2003
Director/Board Member - 16/10/2007
Director/Board Member - 27/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%+3.83%-15.66%-21.28% 137M
+1.74%+0.50%+160.13%+253.34% 17.12B
-0.30%-3.71%-43.47%-26.85% 9.26B
+0.68%-0.73%+31.11%+11.51% 6.72B
+3.44%+2.06% - - 5.05B
-1.64%-0.78%-27.02%-32.16% 4.96B
+10.00%+13.13%+103.07%+100.41% 4.14B
+8.20%+18.95%+217.89%-40.33% 4.08B
-1.27%-6.95%-31.89%-35.59% 3.97B
-1.74%+0.33%-18.54%-43.80% 2.62B
Average +2.00%+2.31%+41.74%+18.36% 5.81B
Weighted average by Cap. +1.78%+1.04%+67.00%+75.42%

Financials

2024 2025
Net sales 1.93B 61.19M 53.32M 49.15M 46.23M 86.49M 5.77B 87.1M 585M 227M 2.84B 230M 225M 9.85B 1.84B 58.18M 50.69M 46.73M 43.95M 82.23M 5.48B 82.81M 556M 216M 2.7B 218M 214M 9.37B
Net income -127M -4.03M -3.51M -3.23M -3.04M -5.69M -379M -5.73M -38.47M -14.94M -187M -15.11M -14.79M -648M -180M -5.7M -4.97M -4.58M -4.31M -8.06M -538M -8.12M -54.51M -21.17M -265M -21.41M -20.95M -918M
Net Debt 2.78B 88.1M 76.76M 70.76M 66.56M 125M 8.3B 125M 842M 327M 4.09B 331M 324M 14.18B 2.57B 81.44M 70.96M 65.41M 61.53M 115M 7.68B 116M 778M 302M 3.78B 306M 299M 13.11B
Logo Bionime Corporation
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
Employees
-
Date Price Change Volume
17/06/26 56.90 NT$ +1.25% 69,619
17/06/26 56.20 NT$ +0.72% 48,181
16/06/26 55.80 NT$ +1.64% 105,679
15/06/26 54.90 NT$ 0.00% 41,929
12/06/26 54.90 NT$ 0.00% 46,805

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4737 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!